The addictive properties of psychostimulants such as cocaine are rooted in their ability to activate the mesocorticolimbic dopamine (DA) system. This system consists primarily of dopaminergic projections arising from the ventral tegmental area (VTA) and projecting to the limbic and cortical brain regions, such as the nucleus accumbens (NAc) and prefrontal cortex (PFC). While the basic anatomy and functional relevance of the mesocorticolimbic DA system is relatively well-established, a key challenge remaining in addiction research is to understand where and how molecular adaptations and corresponding changes in function of this system facilitate a pathological desire to seek and take drugs. Several lines of evidence indicate that inhibitory signaling, particularly signaling mediated by the G i/o class of heterotrimeric GTP-binding proteins (G proteins), plays a key role in the acute and persistent effects of drugs of abuse. Moreover, recent evidence argues that these signaling pathways are targets of drug-induced adaptations. In this review we discuss inhibitory signaling pathways involving DA and the inhibitory neurotransmitter GABA in two brain regionsthe VTA and PFC -that are central to the effects of acute and repeated cocaine exposure and represent sites of adaptations linked to addiction-related behaviors including sensitization, craving, and relapse.
Introduction
Cocaine is a psychomotor stimulant that exerts its effect on both the central and peripheral nervous system, causing heightened arousal, elevated mood, increased behavioral activation, and feelings of euphoria in humans (Koob, 1992) . Cocaine is often consumed by smoking, insufflation, or intravenous injection, ensuring rapid delivery to the bloodstream and brain that produces an intense euphoria revered by addicts. The intensity of the euphoria often leads individuals to increase the dose and frequency of drug use to achieve the desired effects (i.e., tolerance) or to avoid psychological and physiological effects associated with cessation of chronic drug use (i.e., withdrawal) (Cami and Farre, 2003) . An estimated 14.3 million people worldwide reported using cocaine between 2005 and 2006, with 16.2% of Americans having used cocaine in their lifetime (UN World Drug Report, 2007) . Thus, illicit use and abuse of cocaine continues to affect countless individuals, and represents a major portion of the current drug crisis.
The development and persistence of drug addiction relies heavily on the rewarding properties of the drug that motivate the behavior needed to obtain the drug and reinforces repeated drug use (Koob, 1992; Wise, 2002; Everitt and Robins, 2005; Schultz, 2006 Schultz, , 2007 . This is substantiated by the fact that humans and other animals can readily learn to take addictive drugs. For instance, rodents and non-human primates will rapidly learn to press levers to receive an intravenous infusion of cocaine (self-administration), a behavior that perseveres even when a large number of presses are required for each infusion or when lever pressing results in an adverse consequence such as a foot shock (Vanderschuren and Everitt, 2004; Cooper et al., 2007; Pelloux et al., 2007) . In addition to the rewarding properties of the drug, environmental cues (internal and external) associated with drug administration often acquire motivational value (salience) themselves. For example, rats will spend more time in a context in which they passively received an injection of cocaine than in a location paired with a saline injection (conditioned place preference; Tzschentke, 1998) . These drug-associated cues can trigger feelings of drug craving that lead to drug-seeking and drug-taking behavior in both humans and animals, even after prolonged periods of abstinence Crombag et al., 2002; Fuchs et al., 2005 Fuchs et al., , 2006 . Thus, it is believed that addiction involves processes of associative learning, including the formation and retrieval of memories associated with drug use (Hyman, 2005) .
Experience-dependent changes in neural activity modulate gene and protein expression (Leslie and Nedivi, 2011) . Some of these changes yield structural and functional changes in the synaptic connections among neurons. In this way, neural circuitry is constantly finetuned to optimize perception, cognition, and behavioral responses. This fine-tuning is often referred to as 'neural adaptations' or 'plasticity', and is believed to underlie how individuals learn and adapt in their behavior (Nestler, 1993; Berke and Hyman, 2000; Wolf, 2002; Cardinal and Everitt, 2004; Mameli and L ü scher, 2011) . A wealth of research indicates that exposure to drugs of abuse leads to short-and long-term neural adaptations in the brain regions involved in reinforcement, reward, and pleasure that collectively make up the 'reward system' (Nestler, 2001; Wise, 2002; Wolf, 2002; L ü scher and Malenka, 2011; Mameli and L ü scher, 2011) . These changes can often promote an addictive dependence that intrudes upon normal social and personal behaviors by shifting the motivation to obtain natural rewards such as food, sex, and positive social interaction in favor of behavior that is oriented towards drug-seeking and drug-taking (Hernandez and Hoebel, 1988; Damsma et al., 1992; Hansen et al., 1993; Kiyatkin, 1994; . In other words, for addicts, drugs become valued over all other goals, leaving individuals with a narrow focus on obtaining and using drugs. In time, this behavior can become compulsive, leaving individuals with a high risk for relapse even following prolonged periods of abstinence O'Brien et al., 1992; Lubman et al., 2004) .
Drug-induced adaptations occur at both the cellular and molecular level, and include acute and longterm alterations in gene and protein expression. These adaptations in turn promote changes in cell excitability and activity, morphology, and neurotransmission in the reward circuit (Nestler, 2001; Kalivas and O'Brien, 2008; Thomas et al., 2008; L ü scher and Malenka, 2011) . Importantly, drug-evoked neural adaptations outlast the presence of the drug in the brain and are believed to contribute to the reorganization of neural circuits that strengthen the desire to obtain drugs of abuse (Robinson and Berridge, 1993; Shaham and Hope, 2005; L ü scher and Malenka, 2011) .
Several lines of evidence indicate that inhibitory influences on neuronal activity, particularly those mediated by the G i/o class of G protein-coupled receptors (GPCRs) for the neurotransmitters GABA (GABA B R) and dopamine (D 2 R), play key roles in the acute and persistent effects of Behavioral sensitization: A term that refers to the progressive increase in locomotor activity or stereotypy with repeated administration of a psychostimulants. This phenomenon is more likely to occur with intermittent exposure to drugs, and has been suggested to grow with the passage of time. Typically, psychomotor sensitization is viewed as two phases: an initial phase often termed 'development' or 'induction' whereby drugs are administered over days and produce a sequence of cellular and molecular adaptations that lead to enduring changes in neuronal function responsible for drug-induced motor activity. The 'expression of sensitization' typically refers to a subsequent test of motor activity during which subjects are injected acutely with drugs at different withdrawal points following development to assess augmented drug-induced behavior.
drugs of abuse, and are targets of drug-induced adaptations (Nestler et al., 1990; Goldstein and Volkow, 2002; Filip et al., 2007; Vlachou and Markou, 2010) . This review will focus on the relevance and plasticity of metabotropic inhibitory signaling mediated by GABA B R and D 2 R in two brain regions, the ventral tegmental area (VTA) and prefrontal cortex (PFC), which are central to the effects of acute and repeated cocaine exposure and are the sites of neural adaptations linked to addiction-related behaviors such as sensitization, craving, and relapse. We will first, however, review fundamental aspects of the mesocorticolimbic DA system and G protein-dependent signaling. We will then discuss acute and repeated cocaine effects on the physiological properties of the major cell types in the VTA and PFC, followed by some of the underlying mechanisms for these adaptations with an emphasis on how they may influence the development and persistence of addiction.
The mesocorticolimbic dopamine system
The mesocorticolimbic DA system, often referred to as the 'reward circuit', plays a significant role in reinforcement and reward-based associative learning that helps to establish patterns of behavior necessary for obtaining rewards (Berke and Hyman, 2000; Cardinal and Everitt, 2004; Hyman et al., 2005; Schultz, 2006 Schultz, , 2007 Mamelli and L ü scher, 2011) . This circuit mediates responses to motivationally relevant biological stimuli (natural rewards) as well as drugs of abuse and drug-associated cues (Hernandez and Hoebel, 1988; Damsma et al., 1992; Carlezon and Thomas, 2000; Kelley and Berridge, 2002; Wise, 2002; Kelley, 2004; Schultz, 2006 Schultz, , 2007 Stefani and Moghaddam, 2006; Kalivas and O'Brien, 2008; Koob and Volkow, 2010) . Although drugs of abuse are chemically-diverse molecules that exert their initial effects through distinct mechanisms in the brain, drug addiction appears to reflect a convergence of common mechanisms (Wise, 1996; Nestler, 2001 Nestler, , 2005a . Prominent among these shared mechanisms is the engagement of the mesocorticolimbic DA system (Wise, 1996; Jay, 2003; Nestler, 2005a,b) .
Anatomy of the mesocorticolimbic DA system
Central to the mesocorticolimbic DA system are the dopaminergic projections arising from the ventral tegmental area (VTA) (Oades and Halliday, 1987; Cami and Farre, 2003; Feltenstein and See, 2008) . These VTA projections release DA into limbic brain regions such as the nucleus accumbens (NAc), amygdala, and hippocampus (mesolimbic pathway), as well as cortical areas, including the prefrontal, orbitofrontal and cingulate cortices (mesocortical pathway; Figure 1 ). Although the mesocortical and mesolimbic pathways operate in parallel, they also appear to play somewhat distinct roles in addiction (Cami and Farre, 2003) . For example, while the NAc appears to be involved in the primary reinforcing effects of drugs of abuse, the amygdala and hippocampus play an important role in learning that promotes the association of environmental cues present during drug use with the rewarding effects of the drug (Di Chiara, 2002; McLaughlin and See, 2003; See et al., 2003; Volkow et al., 2003; Fuchs et al., 2005 Fuchs et al., , 2007 See, 2005; Rogers and See, 2007) . In contrast, regions of the frontal cortex regulate emotional responses and cognitive control over decision-making (Volkow et al., 1993) . Here, repeated drug use is believed to promote adaptations that diminish inhibitory control over behavior and promote hyper-responsiveness to drug-associated stimuli that prompts persistent addictive behaviors . The mesocorticolimbic dopamine system, with the ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex (PFC) visualized from a sagittal perspective. Dopamine (blue) and GABA (red) projections arising from the VTA synapse on Layer 5/6 pyramidal and GABA local circuit interneurons of the PFC. PFC Layer 5/6 pyramidal neurons also receive GABAergic input from interneurons, and send glutamatergic projections to the NAc and VTA. VTA DA and GABA neurons also project to the NAc and receive reciprocal GABAergic input from neurons of the NAc. In addition, VTA DA neurons receive GABAergic input from local interneurons and neurons projecting from the rostromedial tegmental nucleus (RMTg). Enlarged schematics of the VTA and PFC are shown to illustrate distribution of D 2 (orange) and GABA B (red) receptors.
The mesocorticolimbic DA system and stages of addiction
Addiction is thought to develop in stages, where the pleasurable (rewarding) effects of the drug reinforce repeated intake, which in some individuals leads to regulated, escalating intake (Ahmed et al., 2002; Koob et al., 2004) . The initial rewarding, reinforcing, and stimulatory effects of cocaine are linked in large part to its ability to inhibit transporters tasked with removing DA from the synaptic cleft, allowing extracellular levels of DA levels to rise and persist in downstream targets of the VTA (Ritz et al., 1987; Di Chiara and Imperato, 1988; Pettit and Justice, 1989; Beyer and Steketee, 2001; Carboni et al., 2001; Mateo et al., 2004) . Increased extracellular DA levels in targets of VTA DA neurons also play a critical role in facilitating learned associations between the rewarding effects of the drug and environmental cues (Kiyatkin, 1994; Hyman, 2005; Schultz, 2007) . With repeated drug use, drug-seeking is often triggered by exposure to well-learned drug-associated cues, with enhanced DA neurotransmission 'cueing' the presence of relevant stimuli (Rebec et al., 1997; Cornish and Kalivas, 2001; McFarland and Kalivas, 2001; Jay, 2003; Kelley, 2004; Hyman, 2005; See et al., 2007) . Release of DA in turn triggers activation of glutamatergic projections from cortical regions involved in decision-making such as the medial prefrontal cortex (mPFC) to motor output structures such as the ventral striatum (NAc) and ventral pallidum (Cornish and Kalivas, 2001; Kalivas et al., 2003 Kalivas et al., , 2009 Knackstedt and Kalivas, 2009 ). This PFC-NAc glutamate pathway is critical for the expression of drug-related behaviors, including sensitization and reinstatement of drug-seeking (McFarland and Kalivas, 2001; Baker et al., 2003; McFarland et al., 2003; Cardinal and Everitt, 2004; Moran et al., 2005; Steketee and Kalivas, 2011) . Thus, as drug-seeking becomes well-learned, a reliance of glutamatergic projections from the mPFC emerges (Cardinal and Everitt, 2004; Kalivas et al., 2009; Knackstedt and Kalivas, 2009) . Over time, individuals are believed to experience a reduction in motivation to respond to previously rewarding non-drug-related stimuli, leaving only strong motivational stimuli such as drug-associated cues to ably activate PFC networks and initiate behavior Kalivas and O'Brien, 2008) . At this stage in the disease process (regulated relapse), the individual is thought to retain a certain degree of control over sociallyappropriate decision-making (Kalivas and O'Brien, 2008) .
In some susceptible individuals, however, chronic and extensive cocaine exposure induces a state in which drug-seeking behavior becomes compulsive in nature and the motivational drive to obtain and use drugs is difficult to regulate (Hyman and Malenka, 2001; Lubman et al., 2004; Vanderschuren and Everitt, 2004; Everitt and Robbins, 2005) . This is believed to reflect, in part, a decreased ability of the PFC to cognitively regulate decision-making and behavior (Everitt and Robbins, 2005; Goldstein and Volkow, 2011) . At this stage of the disease, the expression of drug-seeking behavior is thought to rely primarily on activation of neural networks responsible for habit-like behavior, and can be executed without enga ging prefrontal cognitive circuitry (Jog et al., 1999; Packard and Knowlton, 2002; Balleine et al., 2007) . In this way, exposure to drug-associated cues can trigger activation of drug-seeking without a conscious decision ever being made, causing the individual to automatically relapse (Hyman and Malenka, 2001; Lubman et al., 2004; Everitt and Robbins, 2005; Kalivas and O'Brien, 2008) .
While the basic anatomy and functional relevance of the mesocorticolimbic DA system is relatively wellestablished (for review, see Bonci and Malenka, 1999; McFarland and Kalivas, 2001; Everitt and Robbins, 2005; Hyman et al., 2006; Steketee and Kalivas, 2011) , a key challenge remaining in addiction research is to understand where and how neural adaptations, and corresponding changes in function of the mesocorticolimbic DA system, facilitate a pathological desire to seek and take drugs. In the discussion below, we will focus primarily on the relevance of metabotropic inhibitory signaling in the VTA and mPFC to the first two stages of addiction.
Metabotropic inhibitory signaling
All G protein-coupled receptors (GPCRs) share basic functional characteristics. GPCRs transduce ligand-binding events to intracellular responses via heterotrimeric G proteins, which consist of G α and G β γ subunits (Oliveira et al., 1993; Hamm and Gilchrist, 1995) . Binding of a ligand to the GPCR promotes the exchange of GTP for GDP on the G α subunit and dissociation of the G α and G β γ subunits, a process referred to as G protein activation. Activated G α and 'free' G β γ can then interact with and modulate a widerange of intracellular effectors, including cyclases, lipases, and ion channels (Dickey and Birnbaumer, 1993; Wickman and Clapham, 1995; Hall et al., 1999) . To date, at least 18 different G α , 11 G β , and 5 G γ subunits have been identified in the human central nervous system, all of which exhibit genetic diversity and contribute to distinct functional characteristics in different receptor populations (Senogles et al., 1990; Hermans et al., 2003; Wong, 2003) .
The G α subunits have been categorized into several subfamilies (e.g., G s , G i/o , G q ) by virtue of their sequence similarity, modulatory influence, and sensitivity to bacterial toxins (Trumpp-Kallmeyer et al., 1992) . GABA B R and D 2 R couple to and activate the G i/o -subclass of G α subunits. G i/o G proteins are inhibited by pertussis toxin produced by the bacterium Bordetella pertussis (Hille, 1992) . Active G i/o G proteins interact with downstream effectors that decrease neuronal excitability, such as G protein-gated i nwardly-r ectifying K + (Girk/K IR 3) channels, and/or inhibit excitatory effectors, including most isoforms of adenylyl cyclase (AC) and some types of voltage-gated Ca 2+ channels (for review, see Oldham and Hamm, 2008) .
The efficacy of G protein-dependent signal transduction can be altered by multiple mechanisms. Receptor availability, for example, is influenced in part by the level of gene transcription, as well as RNA transcript stability and translation (for review, see Rohrer and Kobika, 1998) . GPCR levels (including GABA B R and D 2 R) at the cell membrane can also be titrated via clathrin-mediated endocytosis (Paspalas et al., 2006; Hanyaloglu, 2008) . Additional factors determine the degree and duration to which those available receptors can be activated. For instance, prolonged agonist-induced stimulation can lead to a reduction in signal transduction via G protein-coupled R eceptor K inases (GRKs) and β -arrestin-mediated deactivation (Pitcher et al. 1998; DeWire et al., 2007) .
The strength of G protein-dependent signaling can also be regulated at the G protein level. G protein activation and deactivation kinetics are dependent on the intrinsic GTPase activity of the G α subunit species and on coupling efficacy of G proteins to downstream effectors (Conklin and Bourne, 1993) . G α GTPase activity is modulated by R egulators of G protein S ignaling (RGS) and A ctivators of G protein S ignaling (AGS) proteins. RGS proteins decrease the effectiveness GPCR-dependent signaling by accelerating the GTPase activity of G α subunits, which in turn enhances the deactivation of G protein signaling (for review, see Ross and Wilkie, 2000) . In contrast, AGS proteins bind to and stabilize GDP-bound G α , thereby inhibiting binding of GTP and preventing reactivation of G α proteins (for review see Blumer and Lanier, 2003) . AGS proteins can also alter G protein availability, thus influencing basal signaling levels independent of GPCR activation.
GABA B R and D 2 R exert an inhibitory influence on neurotransmission at both the presynaptic and postsynaptic levels. In the mesocorticolimbic system, GABA B R and D 2 R can be found at the presynaptic terminal or on the soma and dendrites of GABA and DA neurons where they negatively regulate neurotransmitter release and dampen neuronal activity respectively (Hanh et al., 2006; Kobayashi et al., 2012) . The presynaptic inhibitory influence of D 2 R and GABA B R is often mediated by the G β γ -dependent suppression of voltage-gated calcium channels (Ca V ), which modulate Ca 2+ influx required for neurotransmitter release and neuronal firing (Sakaba and Neher, 2003) . In some instances, however, presynaptic GABA B R and D 2 R act as presynaptic heteroreceptors to regulate release of other neurotransmitters, such as glutamate in the VTA (Koga and Momiyama, 2000) . The postsynaptic inhibitory influence of GABA B R and D 2 R is mediated primarily by G β γ -dependent activation of Girk Binding of a ligand activates G protein signaling by promotes the exchange of GTP for GDP on the G α subunit (2). Activated G α and 'free' G β γ can then interact with and modulate intracellular effectors such as adenylyl cyclase (AC), and ion channels such as G protein-gated inwardly-rectifying potassium (Girk) and voltage-gated calcium (Ca 2+ ) channels (3). G protein-dependent signaling can be regulated by G-protein coupled receptor kinases (grks) dependent phosphorylation and subsequent β -arrestin-mediated internalization (4). Regulators of G protein signaling (RGS) proteins enhance deactivation of G protein signaling by accelerating gtpase activity of G α subunits (5), while activators of G protein signaling (AGS) proteins prevent reactivation of G α proteins by stabilizing GDP-bound G α and preventing binding of GTP (6). channels (L ü scher et al., 1997; Arora et al., 2010) , as well as the inhibition of AC (Martin et al., 1999) .
In summary, there are multiple cellular mechanisms available to regulate GPCR signaling ( Figure 2 ). Variation in the number of receptors, G proteins, effectors, and/or regulators can lead to diverse response profiles. Common regulatory mechanisms include GRK/ β arrestin-mediated GPCR deactivation, clathrin-mediated endocytosis, uncoupling of G proteins, and modulation by AGS and RGS proteins (Bohn et al., 2003; Hanyaloglu, 2008; Kelly et al., 2008) . Importantly, many of the modulatory influences on G i/o signaling mentioned above have been implicated in neural adaptations triggered by drugs of abuse (Bohn et al., 2003; Mor ó n et al., 2006; Federici et al., 2009 ), some of which will be discussed below.
Ventral tegmental area
The VTA lies medial to the substantia nigra (SN) and ventral to the red nucleus close to the midline on the ventral portion of the midbrain and is an important locus for cognitive and emotional brain function as well as reward-driven learning (Bjorklund and Dunnet, 2007; Zellner and Ranaldi, 2010) . It is cyto-architecturally illdefined, with boundaries determined largely by proximity to adjacent structures. Although the VTA is often perceived to be a dopaminergic structure, it is comprised of a heterogeneous population of cells that contains DA (~65%), GABA (~30%) and glutamate (~5%) that project both within and outside the VTA Van Bockstaele and Pickel, 1995; Carr and Sesack, 2000a; Yamaguchi et al., 2007; Dobi et al., 2010) .
The VTA projects densely to the NAc, in addition to the mPFC, amygdala, lateral hypothalamus, and hippocampus (Fuxe et al., 1974; Lindvall et al., 1974; Beckstead et al., 1979; Swanson, 1982) . VTA projections to the NAc and mPFC are comprised of DA, GABA and glutamatecontaining neurons (Van Bockstaele and Pickel, 1995; Carr and Sesack, 2000a; Chuhma et al., 2004; Margolis et al., 2006; Lammel et al., 2008; Gorelova et al., 2012) . Within the mPFC, these projections synapse on the distal dendrites of both pyramidal and local circuit neurons (Carr and Sesack, 2000a,b) . Importantly, DA terminals synapse on mPFC pyramidal cells that project to both the NAc and VTA, providing a mechanism whereby DA can modulate cortical outflow to limbic regions of the brain . Furthermore, while VTA DA neurons project to numerous limbic and cortical structures, most of these neurons do not project to more than one forebrain region (Deniau et al., 1980; Fallon, 1981; Swanson, 1982; Margolis et al., 2006) . These DA neurons display important distinctions in their functional and physiological characteristics depending on their axonal targets, including differences in receptor and ion channel expression, firing pattern, and action potential duration (Lammel et al., 2008; Margolis et al., 2008) .
Role of the VTA in addiction
Drugs of abuse such as cocaine, are powerful triggers of synaptic plasticity in the VTA (Jones and Bonci, 2004; L ü scher and Malenka, 2011) . As such, this brain region plays a critical role in the rewarding, reinforcing, and motor-stimulatory effects of acute and repeated psychostimulant administration (Kalivas and Duffy, 1993; Pierce et al., 1996; Vanderschuren and Kalivas, 2000; Cornish and Kalivas, 2001; Di Ciano and Everitt, 2004; Rebec and Sun, 2005; Sun and Rebec, 2006) . VTA DA release appears necessary for reward and is hypothesized to provide positive reinforcement for drug self-administration and, consequently, initiation of the addiction cycle (Di Chiara and Imperato, 1988; Di Chiara, 1998; Koob et al., 2004; Schultz, 2006) . Drugs of abuse are believed to begin coopting the reward circuitry in the VTA, as early adaptations influence DA transmission in downstream targets of VTA DA neurons, including the NAc and mPFC (Wise and Bozarth, 1987; Di Chiara, 1998; Kauer, 2004; Hyman, 2005; Mameli et al., 2009 ). The hierarchical transfer of drug-related information from the VTA to these and other brain regions promotes the formation of powerful and persistent links between the rewarding aspects of the drug experience and environmental cues present during drug use. These associations are important to the development and prolonged expression of addicted behavior (Kalivas and Duffy, 1993; McFarland and Kalivas, 2001; Rebec and Sun, 2005) .
Effects of cocaine on VTA DA neurons
When administered acutely, cocaine potentiates DA neurotransmission in brain regions innervated by DA neurons by blocking the transporter-dependent reuptake of extracellular DA at the synapse (Ritz et al., 1987; Di Chiara and Imperato, 1988; Bradberry and Roth, 1989) . Studies in acutely-isolated brain slices containing the VTA, however, show that acute cocaine decreases the firing rate of spontaneously-active DA neurons (Brodie and Dunwiddie, 1990) . Similarly, in vivo experiments demonstrated that midbrain DA neuron firing is partially inhibited following acute cocaine, with VTA DA neurons exhibiting a reduction in activity immediately following an intravenous infusion of the drug (Pitts and Marwah, 1987; Einhorn et al., 1988; Lacey et al., 1990) .
In contrast to the effect of acute cocaine, the number of spontaneously active VTA DA cells and their basal firing rates are significantly increased immediately after discontinuation of repeated systemic cocaine treatment, an effect that has been shown to last up to 7 d following cessation of cocaine administration (Henry et al., 1989; Ackerman and White, 1990; Gao et al., 1998) . Likewise, cocaine selfadministration increases the mean firing rate and bursting activity of VTA DA neurons 1 -3 days, but not 10 days following the conclusion of self-administration (Marinelli et al., 2003) . Together, these studies indicate that acute and repeated cocaine exerts a bi-directional effect on the activity of VTA DA neurons, and that cocaine-induced adaptations in VTA DA neuron activity are temporary, with the system 're-setting' shortly after the end of drug-treatment.
A wealth of evidence highlights the importance of drug-induced adaptations in excitatory neurotransmission in the VTA to the cellular and behavioral effects of acute and repeated cocaine exposure (Robinson and Berridge, 1993; Everitt and Wolf, 2002; Jones and Bonci, 2005; Shaham and Hope, 2005; Hyman et al., 2006; Kauer and Malenka, 2007; Van den Oever et al., 2010) . Within 3 h of a single cocaine injection, VTA DA neurons display enhanced strength at glutamatergic synapses, an adaptation requiring NMDA receptor activation and synaptic insertion of GluR1-containing AMPA receptors (Ungless et al., 2001; Saal et al., 2003; Bellone and L ü scher, 2006; Argilli et al., 2008) . This augmented excitatory neurotransmission is believed to trigger persistent changes in DA cell signaling that are at least in part responsible for the early behavioral consequences of exposure to cocaine (Robinson and Berridge, 1993; Kalivas, 1995; Wolf, 1998; Everitt and Wolf, 2002; Borgland et al., 2004) . There are a number of excellent reviews that describe the current state of knowledge regarding psychostimulant-induced adaptations in DA neuron excitatory transmission (Jones and Bonci, 2005; Thomas and Malenka, 2003; L ü scher and Malenka, 2011) .
D 2 R and GABA B R in the VTA
The output of VTA DA neurons is dependent on a delicate balance of excitatory and inhibitory input (White, 1996; Carr and Sesack, 2000a; Omelchenko and Sesack, 2005) . VTA DA neurons receive negative autocrine and paracrine (long-loop) feedback mediated by D 2 R and GABA B R, respectively (Einhorn et al., 1988; Sugita et al., 1992) . In the VTA, D 2 Rs are located primarily on the soma and dendrites of DA neurons (Sesack et al., 1994) . These receptors are activated by somato-dendritic DA release and serve as autoreceptors that decrease DA neuron firing rates. In contrast, D 2 Rs localized to DA axon terminals in target brain regions of the VTA inhibit DA release at the presynaptic level (Cubeduu and Hoffman, 1982; Lacey, 1987; Einhorn et al., 1988; Lacey et al., 1990; Beckstead et al., 2004) .
GABA is also an important determinant of VTA DA function (Dewey et al., 1992; Klitenick et al., 1992; Sugita et al., 1992; Engberg and Nissbrandt, 1993; Cruz et al., 2004; Labou è be et al., 2007) . GABAergic input to VTA DA neurons arises from local interneurons of the VTA and from striatal regions, including the NAc and ventral VP, that synapse selectively onto GABA-containing neurons projecting to the NAc, thus providing a potential 'long-loop' inhibitory feedback mechanism to regulate meso limbic activity (Walaas and Fonnum, 1980; Smith and Bolam, 1990; Johnson and North, 1992; Groenewegen et al., 1993; White, 1996; . Afferents from the VP and NAc preferentially activate GABA B R, while the inhibitory influence of local GABA interneurons is typically mediated by the ionotropic GABA A R (Sugita et al., 1992) . Recently, a primarily GABAergic structure located just posterior to the VTA, termed the rostromedial tegmental nucleus (RMTg), was shown to selectively target VTA DA neurons and regulate their spontaneous activity and responses to drugs of abuse (Lecca et al., 2011) . The complexity of GABAergic signaling in the VTA is further enhanced by the presence of GABA B Rs on GABA neurons in the VTA, where they are found at both pre-and postsynaptic locations (Cruz et al., 2004; Padgett and Slesinger, 2010) . Collectively, the above insights argue that GABA B R and D 2 R exert an inhibitory influence on VTA neurons through pre-and postsynaptic mechanisms within the VTA.
Several lines of evidence indicate that inhibitory neurotransmission mediated by GABA B R and D 2 R is a critical determinant of cellular and behavioral responses to acute and repeated cocaine exposure in the VTA. Indeed, acute cocaine exposure evokes negative autocrine and para crine feedback loops mediated by D 2 R and GABA B R, respectively (Einhorn et al., 1988; Sugita et al., 1992) . These negative feedback loops temper VTA DA neuron output in response to acute cocaine, and are weakened by repeated cocaine exposure (Ackerman and White, 1990; Kushner and Unterwald, 2001; Febo et al., 2003) . Moreover, inactivation of G i/o proteins with pertussis toxin produced an enhanced response to acute cocaine that resembled motor activity observed following repeated exposure (behavioral sensitization; Steketee and Kalivas, 1991) . What follows is a summary of cocaine-induced adaptations in GABA B R-and D 2 R-dependent signaling, the possible underlying mechanisms, and how these adaptations may influence the development and persistence of addiction.
Cocaine-induced adaptations in VTA D 2 R signaling
The reduced activity of VTA DA neurons that were observed following acute cocaine exposure, results from the blockade of re-uptake of DA released at somato-dendritic sites within the VTA and subsequent stimulation of D 2 R found on DA neurons (Lacey et al., 1987; Bradberry and Roth, 1989; Brodie and Dunwiddie, 1990; Beckstead et al., 2004) . Consistent with this, cocaine-induced decreases in the activity of VTA DA neurons is blocked by prior application of the D 2 R antagonist sulpiride (Brodie and Dunwiddie, 1990 ). Furthermore, mice lacking D 2 R display a complete loss of autoreceptor-dependent regulation of DA release and increases in extracellular DA levels in the NAc following acute cocaine that are dramatically higher than that observed in wild-type counterparts (Rouge-Pont et al., 2002) . Together, these studies suggest that D 2 Rdependent signaling in the VTA normally tempers VTA DA neuron output, and that this inhibitory signaling mechanism remains intact immediately following acute cocaine exposure.
Persistent stimulation of D 2 R in the VTA, however, can lead to a reduction in autoreceptor function (Nimitvilai and Brodie, 2010) . Indeed, electrophysiological, pharmacological, and behavioral studies have consistently shown that increases in mesocorticolimbic DA transmission triggered by repeated cocaine exposure correlate with a reduction in the influence of D 2 R on VTA DA neuron output (Henry et al., 1989; Ackerman and White, 1990; Kalivas and Stewart, 1991; Steketee and Kalivas, 1991) . In vitro studies have shown that following repeated non-contingent cocaine, VTA DA neurons display a reduction in D 2 R agonist-dependent inhibition of DA neuron activity that is paralleled by a significant increase in the number of spontaneously-active DA neurons and an increase in burst firing activity (Henry et al., 1989) . Similarly, in vivo electrophysiology studies in anesthetized rats demonstrated that the D 2 R agonist quinpirole is unable to quell increased firing and burst activity exhibited by VTA DA neurons 24 h following the end of cocaine self-administration, but can once again suppress activity 10 days post drug administration (Marinelli et al., 2003) . Thus, repeated cocaine exposure initially reduces the inhibitory functions of D 2 R in the VTA that leads to augmented VTA DA neuron output. However, cocaine-induced increases in DA cell activity dissipate over time, with both activity and D 2 R sensitivity returning to normal following approximately 10 days of withdrawal.
VTA D 2 R adaptations and addiction-related behavior
Cocaine-induced locomotor activity and drug-seeking behavior are associated with alterations in the D 2 Rdependent inhibition of VTA DA neuronal activity. Heightened spontaneous activity and burst firing of DA neurons following repeated cocaine is correlated with a progressive increase in cocaine-induced motor activity and DA release in downstream targets of the VTA (Kalivas and Stewart, 1991; Kalivas and Duffy, 1993; McFarland and Kalivas, 2001; Marinelli et al., 2003) . As D 2 R autoreceptors play a critical role in regulating activity of DA neurons, and given the evidence that this inhibitory pathway is reduced by repeated cocaine exposure, it is likely that the progressive increase in DA signaling and cocaine-induced behavior observed with repeated cocaine exposure is due to a reduction in D 2 R function within the VTA. Consistent with this hypothesis, repeated systemic quinpirole treatment in rats produced a reduction in D 2 R sensitivity in the VTA and promoted sensitization to subsequent cocaine exposure for up to 1 week following the end of drug treatment (Henry et al., 1998) . Furthermore, mice lacking D 2 R displayed elevated DA synthesis and release that correlated with heightened sensitivity to the psychomotor effects of cocaine and enhanced cocaine place preference (Bello et al., 2011) .
The importance of altered D 2 R function in the development of addiction has been further underscored by studies examining how rats respond to a novel environment, as it predicts behavioral and neurochemical responses to psychostimulant drugs. For example, rats displaying higher locomotor responses [high-responding (HR)] to a novel environment exhibit a greater probability of acquiring and maintaining cocaine self-administration (Deroche et al., 1995; Grimm and See, 1997; Marinelli and White, 2000) . Additionally, HR rats display augmented cocaine-induced motor activity and DA release within the NAc, and more readily develop behavioral sensitization as compared to rats with a lower response (Hooks et al., 1991a,b) . HR rats also exhibited greater activity of midbrain DA neurons that was paralleled by reduced sensitivity to D 2 R agonists (Marinelli and White, 2000; Marinelli et al., 2003) . Further indications that altered function of VTA D 2 R signaling can promote drug-related behavior stems from a recent study showing that intra-VTA infusion of quinpirole dose-dependently decreased cocaine-induced reinstatement of drug-seeking behavior (Xue et al., 2011) . Thus, intrinsic differences in D 2 R-dependent signaling may underlie the unique susceptibility of certain individuals to psychosti mulant addiction.
Together, these findings highlight the importance of somatodendritic D 2 R in the VTA and demonstrate that reductions in this inhibitory signaling pathway can contribute to augmented drug-induced DA neurotransmission that is important for cocaine-induced sensitization, reinstatement of drug-seeking, and the rewarding properties of cocaine. Cocaine-induced decreases in D 2 R function within the VTA, however, are transient. Thus, this adaptation likely represents an early neural adaptation that temporarily alters mesocorticolimbic DA signaling necessary for the emergence of DA-dependent changes in the physiology and function of brain regions downstream of the VTA that are responsible for enduring expression of addicted behavior.
Cocaine-induced adaptations in VTA GABA B R signaling GABA B R-dependent signaling is targeted by cocaine in both DA and GABA neurons of the VTA. A single exposure to cocaine triggers a robust and selective suppression of postsynaptic GABA B R-dependent inhibition in VTA (but not substantia nigra) DA neurons that persists up to 4 days following drug exposure and is paralleled by enhanced glutamatergic signaling in the same neurons (Arora et al., 2011) . These adaptations are similar in magnitude and duration following repeated cocaine exposure, indicating that a single cocaine injection is sufficient to saturate the plasticity of this form of inhibitory signaling in VTA DA neurons. Furthermore, weakening of inhibitory signaling in VTA DA neurons, as is predicted with the cocaineinduced suppression of GABA B R-dependent signaling, is consistent with behavioral sensitization seen following repeated cocaine. But while behavioral sensitization is a long-lasting phenomenon, the strength of GABA B Rdependent signaling in VTA DA neurons recovers within 10 days of the final cocaine exposure (Arora et al., 2011) . Thus, GABA B R signaling within VTA DA neurons may constitute an 'addiction barrier' that is overcome by exposure to cocaine to promote the development, but not expression of more persistent drug-related behavior.
Recently, it was found that a single systemic cocaine exposure also depressed GABA B R-dependent signaling in VTA GABA neurons 24 h following drug exposure. A reduction in GABA B R-dependent signaling in GABA neurons of the VTA following acute cocaine would likely enhance GABAergic transmission onto VTA DA neurons. Nevertheless, VTA DA neuron activity is enhanced following repeated cocaine (White and Wang, 1984; Henry et al., 1989; White, 1996) . It is possible that the reduction in inhibitory feedback in VTA GABA neurons reflects a form of synaptic scaling in an attempt to restore balance in activity of the VTA circuit (Padgett et al., 2012) . Importantly, this down-regulation of GABA B R-dependent signaling in VTA GABA neurons occurs in concert with other drug-induced adaptations in VTA DA neurons, including enhanced glutamatergic signaling and reduced GABA and DA-dependent inhibition which all serve to facilitate the output of VTA DA neurons. Thus, it is conceivable that decreased GABA B R tone in VTA GABA neurons and enhancement of GABA release may be inadequate to suppress the potentiating effects of cocaine on VTA neuron output (Padgett et al., 2012) . However, additional efforts are needed to better understand how adaptations in GABA B R-dependent signaling affect VTA neuron function that might provide a strategy for treating addiction.
VTA GABA B R adaptations and addictionrelated behavior
Local administration of the GABA B R agonist baclofen can reduce firing rate and burst firing of VTA DA neurons and restore tonic DA neuron firing, while application of GABA B R antagonists have an inverse effect (Erhardt et al., 2002 ; but see Cruz et al., 2004; Chen et al., 2005) . In non-contingent animal models of cocaine addiction, intra-VTA administration of baclofen prevents acute cocaine-induced (but not spontaneous) locomotor activity in rats, and attenuates heightened extracellular DA levels in the NAc and mPFC that normally accompany repeated cocaine-induced motor activity (Kalivas et al., 1990; Kalivas and Duffy, 1990; Klitenick et al., 1992; Westerink et al., 1996) . Moreover, intra-VTA baclofen reduces operant responding maintained by cocaine and dose-dependently attenuates cocaine self-administration under both fixed-ratio (FR) and progressive ratio (PR) schedules of reinforcement (Brebner, 2000; Backes and Hemby, 2008) . Thus, alterations in GABA B R-dependent signaling triggered by cocaine might profoundly affect the function of VTA DA neurons and the reinforcing properties of cocaine.
Mechanisms underlying adaptations in VTA D 2 R and GABA B R signaling Receptor expression
Acute and repeated cocaine administration tempers GABA B R-and D 2 R-dependent signaling, respectively, within the VTA (Henry et al., 1989; Ackerman and White, 1990; Arora et al., 2011) . Conflicting results related to the effects of repeated pyschostimulant exposure on D 2 R expression levels in the VTA have been reported, with differences perhaps attributable to drug-type, mode of administration, and animal model employed. For example, D 2 R mRNA expression is increased in the VTA following 5 weeks of cocaine self-administration, but not in passive yoked-cocaine in rodents (Stefanski et al., 2007) . However, D 2 R mRNA is not altered 20 min or 14 days following 2 weeks of self-administration (BenShahar et al., 2007) . Furthermore, no differences in D 2 R binding were observed in the VTA of either rodents or non-human primates following cocaine self-administration (Moore et al., 1998; Stefanski et al., 2007) . Thus, the increase in D 2 R expression following prolonged cocaine self-administration likely reflects a neuroadapative proliferation to compensate for decreased D 2 R function within the VTA. Similarly, a number of studies have demonstrated that neither acute nor repeated non-contingent cocaine alters total GABA B R mRNA or protein expression in the VTA (Li et al., 2002; Arora et al., 2011) . Collectively, these data indicate that changes in the activity of VTA DA and GABA neuron activity following cocaine exposure are not likely due to alterations in total D 2 R and GABA B R expression.
G proteins
Long-term adaptations in G protein expression and/ or function can also contribute to the development of addicted behavior (Nestler and Aghajanian, 1997; Nestler, 2001) . Early studies of cocaine-induced adaptations in GABA B R signaling showed that repeated cocaine decreased functional coupling of the GABA B R (as measured by baclofen-stimulated 35 S -GTP γ S binding) in the rat VTA, but not PFC, NAc, substantia nigra, or dorsal striatum (Kushner and Unterwaldt, 2001) . Moreover, repeated non-contingent cocaine reduced G i/o -protein immunoreactivity and pertussis-toxin stimulated ADP-ribosylation of G i/o signaling in the VTA (Nestler et al., 1990) . These adaptations were transient, however, as ADP-ribosylation returned to baseline within 24 h and no changes in G α i protein levels were found 2 weeks following drugexposure (Striplin and Kalivas, 1992; Striplin and Kalivas, 1993) . Taken together, these data indicate that alterations in G i/o G protein expression in the VTA contributes, at least in part, to early adaptations in the VTA inhibitory signaling that are necessary for the development of addicted behavior.
Effectors
Decreased GABA B R-and D 2 R-dependent signaling observed following acute and chronic cocaine administration in the VTA could also be attributed to alterations in the level or function of G protein-modulated effectors. VTA DA neuron excitability is influenced by Girk channels coupled to somatodendritic GABA B R and D 2 R Beckstead et al., 2004; Cruz et al., 2004; Labou è be et al., 2007) . Moreover, Girk channels have been found to mediate most, if not all, of the somatodendritic inhibitory effects of GABA B R and D 2 R on VTA DA neurons (Beckstead et al., 2004; Cruz et al., 2004) .
The acute cocaine-induced suppression of GABA B R signaling in VTA DA neurons was shown to reflect a lower density of Girk2-containing channels on the somatodendritic membrane of VTA DA neurons; GABA B R receptor level was unaffected by cocaine (Arora et al., 2011) . Interestingly, the cocaine-induced reduction in GABA B Rdependent signaling was prevented by prior systemic administration of a D 2/3 R (Sulpiride) but not D 1 R (SCH23390) antagonist. While cocaine-induced stimulation of VTA D 2 R may mediate the suppression of Girk signaling in DA neurons, this adaptation may also be triggered by stimulation of D 2/3 R in striatal or cortical brain regions that project back to the VTA (Arora et al., 2011) . Additionally, although the exact mechanisms responsible for cocaine-induced suppression of GABA B R-dependent signaling in VTA GABA neurons remains unclear, acute administration of methamphetamine suppressed GABA B R-Girk signaling in VTA GABA neurons via the internalization of both receptor and channel that coincided with dephosphorylation of a serine residue on the GABA B R that has been implicated in regulating GABA B R surface expression (Padgett et al., 2012) .
In addition to drug-induced adaptations in G proteindependent ion channel activity, disruption of G i/o signaling within the VTA may reflect alterations in downstream signaling molecules associated with these receptors that alter physiological properties of VTA DA neurons. Pharmacological up-regulation of cAMP in VTA slice preparations attenuates DA-dependent firing of DA neurons, while inhibition of protein kinase A (PKA) potentiates these effects (Shi and Bunney, 1992) . Thus it is possible that repeated psychostimulant exposure reduces G i/odependent negative regulation of AC activity that results in a significant increase in cAMP production and subsequent PKA activity in VTA neurons. Indeed, antagonism of G s -coupled D 1 -like receptors known to activate AC and promote cAMP production can block the development of behavioral sensitization to systemic cocaine (Vezina and Steward, 1989; Kalivas, 1994) . Furthermore, constitutive activation of AC with an intra-VTA infusion of cholera toxin promotes behavioral sensitization to psychostimulants, an effect that is blocked by inhibition of PKA signaling (Pierce et al., 1996) .
Regulatory proteins
RGS and AGS proteins have emerged as potential targets of drug-induced adaptations that occur during the development of addiction (Hooks et al., 2008; Lomazzi et al., 2008) . Numerous studies have demonstrated that RGS and AGS expression and protein levels are dynamically-regulated following exposure to drugs of abuse (for review, see Lomazzi et al., 2008) . The localization of Rgs2 and Rgs4 in VTA neurons led to early speculation that these proteins may modulate responses to psychostimulants and other drugs of abuse (Hooks et al., 2008; Lomazzi et al., 2008) . Rgs2 is highly-enriched in striatal regions associated with psychostimulant-related behavior, and is heavily expressed in VTA DA neurons where it is serves as a negative regulator of GABA B R-Girk signaling (Labou è be et al. 
Conclusion
Although drug-related behaviors such as sensitization, craving, and susceptibility to relapse are long-lasting phenomena, adaptations in metabotropic inhibitory signaling discussed above typically recover within 10 -12 days following a repeated non-contingent cocaine administration regimen. Thus, these adaptations may contribute to the development of drug-related behavior, but are not likely required for their continued expression. It is possible, however, that the transient nature of these changes reflects the model of cocaine administration used, as cocaineinduced changes in excitatory transmission following systemic cocaine administration are short lasting, but can persist up to 3 months following cocaine exposure when delivered intravenously in a self-administration model of drug-seeking (Chen et al., 2008) . Future efforts to define the anatomic, genetic, and temporal bases of these disparate adaptations in the VTA may provide important insight into how early and transient cocaine-induced adaptations facilitate the longer-lasting and stable changes that promote chronic cocaine intake.
Prefrontal cortex
The frontal cortex is an aggregate of several cortical regions, including the cingulate, prelimbic (PL), infralimbic (IL) and orbitofrontal cortices (OFC), and provides widespread excitatory (glutamatergic) input to cortical and subcortical structures. Recent findings in rodents and nonhuman primates suggest that these sub-regions display important similarities with humans in their reciprocal and topographical connectivity (Krettek and Price, 1977; Kolb and Gibb, 1990; Uylings and van Eden, 1990; van Eden et al., 1990; Groenewegen et al., 1997) . We will focus here on the more medial aspects of the PFC (mPFC), mainly the PL, IL, and cg1/cg2 aspects of the cingulate. These regions provide a majority of the glutamatergic excitatory projections to limbic structures such as the VTA and NAc, and are densely-innervated by projections arising from the VTA ( Sesack et al., 1989; Sesack and Pickel, 1992; . As such, they act as critical elements of the brain reward circuitry responsible for mediating responses to rewards and reward-predicting stimuli (Goldstein and Volkow, 2011; Noonan et al., 2011; O'Doherty, 2011; Rushworth et al., 2011) .
The rodent mPFC is divided into distinct cytoarchitectonic layers (layers 1 -6); unlike humans and non-human primates, the rodent mPFC lacks a distinguishable layer IV (Krettek and Price, 1977; Conde et al., 1995; Gabbot et al., 1997) . Glutamatergic pyramidal neurons found in layers 2/3 and 5/6 make up 85% of neurons found within the mPFC (Kawaguchi, 1993; Kawaguchi and Kubota, 1993) . Layer 5/6 pyramidal cells are the primary output neurons of the mPFC and play an important role in regulating the activity of VTA and NAc neurons ( Sesack et al., 1989; Sesack and Pickel, 1992; . Within the VTA, mPFC terminals synapse onto GABA-containing neurons that project to the NAc, and DA-containing neurons that project to the mPFC, providing a mechanism to influence activity of ascending DA and GABA projections of the VTA .
Role of the mPFC in addiction
While the VTA and DA have received considerable attention as key players in drug addiction, recent studies have highlighted the role of the mPFC and glutamate in the modulation of the mesocorticolimbic DA system and drug-seeking behavior (Taber and Fibinger, 1995; Reid et al., 1997; McFarland and Kalivas, 2001; Baker et al., 2003; Cardinal and Everitt, 2004; Moran et al., 2005; Steketee and Kalivas, 2011) . The PFC plays an intricate role in decision-making, goal-directed behavior, and the processing of reward-related information (Williams and Goldman-Rakic, 1995; Roberts and Wallis, 2000; Rolls, 2000; Volkow et al., 2003; Goldstein and Volkow, 2011) . This structure is also involved in mediating the primary rewarding and reinforcing effects of abused drugs and drug craving (Goeders and Smith, 1983; Koob and Volkow, 2010; Steketee and Kalivas, 2011) .
One of the core theories explaining how addictionrelated behavior becomes compulsive is that a functionally 'hypoactive' frontal cortex results in decreased inhibitory control over behavior and an inability to regulate drugseeking Volkow, 2002, 2011; Feil et al., 2010; Koob and Volkow, 2010) . Clinical studies indicate that structural, physiological, and functional abnormalities within the PFC facilitate impaired decision-making and the development of addicted behavior such as drug craving and drug seeking Foltin and Haney, 2000; Franklin et al., 2002) . For example, imaging studies in humans reveal that cerebral blood flow and glucose metabolism in the frontal cortices of cocaine addicts is decreased during withdrawal but increased during intoxication and exposure to drug-associated cues, the latter of which correlates with self-reported feelings of craving Maas et al., 1998; Childress et al., 1999; London et al., 2000; Volkow and Fowler, 2000; Bonson et al., 2002; Franklin et al., 2002; Matochik et al., 2003) . Similar drug-induced changes have been shown in rodent models of addiction. For example, repeated cocaine exposure decreases mRNA levels of neuronal activity markers such as brain-derived neurotrophic factor ( bdnf ), activity-regulated cytoskeleton-associated ( arc ) gene, and zif/268 Hearing, personal communication, 2010) , while exposure to cocaine-associated cues following prolonged abstinence increases expression of activity-regulated genes in the mPFC (Neisewander et al., 2000; Hearing et al., 2008) .
Several lines of evidence indicate that intact but altered glutamatergic output from the mPFC to limbic brain regions plays a critical role in the expression of drugrelated behaviors (Tzschentke, 2000; Tzschentke and Schmidt, 2000) . For instance, lesioning of the ventral (IL cortex) and dorsal (PrL cortex) aspects of the mPFC prevents the development and expression of cocaine-induced behavioral sensitization, respectively (Pierce et al., 1998; Steketee and Kalivas, 2011) . Moreover, drug-induced adaptations in cortical glutamate release onto neurons of the NAc and the VTA are key contributors to reinstatement of cocaine-seeking behavior (McFarland and Kalivas, 2001; Baker et al., 2003; Moran et al., 2005; Liu and Steketee, 2011; Lu et al., 2012) . Thus, corticomesolimbic glutamate transmission arising from Layer 5/6 pyramidal neurons of the mPFC mediates several aspects of addiction-related behavior, including sensitization to cocaine, drug-taking behavior, and relapse (Pierce et al., 1996; McFarland and Kalivas, 2001; McFarland et al., 2003; Sun et al., 2005; Steketee and Kalivas, 2011) . A critical unresolved question, however, is what specific adaptations occur in the mPFC in response to drugs of abuse (Wolf, 1998; Hyman and Malenka, 2001 ).
Effects of cocaine on mPFC neuron activity
To date, few studies have explored the acute effects of cocaine on prefrontal cortical activity. In vivo electrophysiological studies demonstrate that acute administration of cocaine significantly depolarizes layer 5/6 pyramidal neurons shortly after cocaine administration (TranthamDavidson et al., 2004) . Moreover, acute cocaine decreased the spontaneous firing rate of pyramidal neurons, and decreased VTA-evoked postsynaptic responses . However, in vitro studies in acute slices has shown that membrane excitability of layer 5/6 pyramidal neurons is not altered 24 h following a single cocaine exposure, nor by 10 min of direct cocaine (1 μ m) perfusion (Dong et al., 2005) , indicating that acute administration of cocaine transiently alters certain physiological properties of mPFC Layer 5/6 pyramidal cells and may have a role in mediating some of the immediate behavioral effects of cocaine.
Studies on the effects of repeated cocaine on neuronal activity in the mPFC has been explored in greater detail, but paints a complex and often contradictory picture. In vivo electrophysiological recordings in cocaine self-administering rats showed that during an initial selfadministration session, the overall firing rate and burst frequency of layer 5/6 pyramidal neurons of the mPFC was reduced following cocaine infusion (Sun and Rebec, 2006) . However, such inhibitory effects were no longer apparent following 2 weeks of cocaine self-administration, with burst firing rates and duration significantly elevated compared to baseline during the self-administration session (Sun and Rebec, 2006) . Importantly, basal activity of layer 5/6 pyramidal neurons of the mPFC prior to the beginning of a self-administration session decreased after extended cocaine, indicative of a 'hypofrontal' state of activity (Sun and Rebec, 2006) . Moreover, in vitro studies in acute mPFC slices have shown that repeated cocaine exposure triggers enduring plasticity within glutamatergic pyramidal neurons, including increased membrane excitability and strengthened excitatory signaling 3 days following the end of drug treatment (Dong et al., 2005; Huang et al., 2007a,b) . Together, these studies suggest that while repeated cocaine exposure decreases basal activity of mPFC layer 5/6 neurons, these cells are more excitable and responsive to cocaine-related information (Sun and Rebec, 2006) . It has been suggested that lower basal activity within the mPFC may amplify responsiveness of this brain region to drugs and drug-conditioned cues, allowing these cues to exert greater control over behavior (Sun and Rebec, 2006) .
One potential consequence of increased excitability and responsiveness of Layer 5/6 pyramidal neurons to drug-associated cues would be increased glutamate release in the mesocorticolimbic system. Indeed, increased glutamate release has been observed in the NAc, VTA, and the mPFC following cocaine administration (Smith et al., 1995; Pierce et al., 1996; Reid et al., 1997; Kalivas and Duffy, 1998; Kozell et al., 2001 ). This rise in glutamate release can be blocked by inactivation of the mPFC and has been shown to correlate with drug-seeking behavior (McFarland and Kalivas, 2001; McFarland et al., 2003; Steketee, 2003; Steketee and Kalivas, 2011) .
D 2 R and GABA B R signaling in the mPFC
The output of mPFC layer 5/6 projection neurons is dependent on their intrinsic physiological properties in conjunction with inhibitory tone produced by GABA and DA through direct and/or multi-synaptic inputs. Electrical stimulation of the VTA and local application of dopamine inhibit the spontaneous activity of most prefrontal cortical neurons, including layer 5/6 projection cells (Pirot et al., 1992) . DA afferents arising from the VTA synapse onto both pyramidal and GABAergic neurons within layer 5/6 of the mPFC (Goldman-Rakic et al., 1989; Cowan et al., 1994; Sesack et al., 1995) , signaling through postsynaptic D 1 and D 2 -like receptors (Wolf and Roth, 1987; Bean et al., 1990; al-Tikriti et al., 1992) . In the rodent mPFC, both D 1 -like and D 2 -like receptors are found on pyramidal and non-pyrmaidal neurons (Vincent et al., 1993 (Vincent et al., , 1995 Benes and Berretta, 2001) . DA has been shown to exert both excitatory and inhibitory effects on mPFC Layer 5/6 pyramidal cells that are dependent on the DA concentrations and the physiological state of the cell (Shi et al., 1997; Gulledge and Jaffe, 1998, 2001; Lavin and Grace, 2001; . Furthermore, in vitro and in vivo studies have demonstrated that intra-mPFC delivery of the D 2 R agonist quinpirole can enhance extracellular GABA levels within the mPFC but inhibit evoked release of GABA (Grobin and Deutch, 1998; Gulledge and Jaffe, 1998) . Thus, DA can directly influence layer 5/6 pyramidal cell output through activation of postsynaptic DA receptors on pyramidal neurons or through modulation of local GABA neurons in the mPFC (for review, see Seamans and Yang, 2004) .
GABA is the major inhibitory neurotransmitter in the mPFC, and it plays a fundamental role in regulating neuronal excitability (Bowery and Smart, 2006; Steketee, 2003) . Local GABA neurons, which account for ~15% of neurons in the mPFC, synapse onto and provide one source of GABA to mPFC pyramidal neurons (Hendry et al., 1983; Kawaguchi, 1993; Kawaguchi and Kubota, 1993; Retaux et al., 1993) . Additionally, GABA-containing neurons in the VTA send axons to the mPFC where they synapse on dendrites of both pyramidal and local circuit neurons (Carr and Sesack, 2000a) . GABA exerts its effects through activation of both ionotropic (GABA A R) and metabotropic (GABA B R) receptors (Sivilotti and Nistri, 1991; Bowery et al., 2002) . Within the mPFC, GABA B Rs are found presynaptically on axon terminals from local GABAergic interneurons and VTA GABA projection neurons and mediates postsynaptic inhibitory responses on layer 5/6 neurons (Badran et al., 1997; Aguilar-Garcia et al., 2000; Calver et al., 2002) .
Adaptations in D 2 R signaling in mPFC Layer 5/6 pyramidal neurons
Repeated cocaine exposure alters DA signaling in layer 5/6 pyramidal cells of the mPFC. In vivo electrophysiology studies in anesthetized rats have shown that prolonged withdrawal from repeated non-contingent cocaine decreases D 2 R-mediated regulation of mPFC pyramidal cell excitability, reduces postsynaptic responses to evoked DA release from the VTA, and reduces currentevoked but not spontaneous firing (excitability) of mPFC pyramidal cells (Nogueira et al., 2006) . Additionally, behavioral studies indicate that repeated cocaine exposure decreases mPFC D 2 R modulation of glutamate neurotransmission from the PFC that results in enhanced extracellular glutamate levels in the NAc (Beyer and Steketee, 2002) . Given that activation of D 2 Rs has a hyperpolarizing effect on neurons, it seems likely that reduced D 2 R-function in mPFC pyramidal neurons would enhance the excitability of these cells, akin to previous findings in mPFC slices from cocaine-treated animals (Dong et al., 2005; Nasif et al., 2005) . However, reduced D 2 R-dependent postsynaptic inhibition was paralleled by a trend towards decreased excitability of layer 5/6 pyramidal neurons in vivo (Nogueira et al., 2006) , indicating that cocaine treatment likely alters intrinsic currents in pyramidal neurons as well as dopaminergic signaling within the mPFC. The contradictory nature of cocaine-induced changes in excitability likely reflects differences in the duration of withdrawal (3 days vs. 2 weeks) or that recordings from in vivo studies were performed in adult rats (3 months old) versus in vitro studies in younger animals (4 -6 weeks old).
D 2 R adaptations in mPFC Layer 5/6 pyramidal neurons and addiction-related behavior
Reduced D 2 R expression in frontal cortices has been implicated in compulsive drug intake in human cocaine addicts and decreased cognitive function in rats self-administering cocaine (Volkow et al., 1993; Briand et al., 2008) . IntramPFC infusion of the D 2 R antagonist sulpiride enhanced acute cocaine-induced motor activity and NAc extracellular DA levels, while a D 2 R agonist inhibited both the behavioral and neurochemical effect of acute cocaine Steketee, 2000, 2001; Steketee and Walsh, 2005) . Moreover, repeated intra-mPFC sulpride induced a behavioral and neurochemical cross-sensitization to cocaine, while intra-mPFC quinpirole given prior to daily cocaine injections prevented the development of sensitization (Beyer and Steketee, 2002; Steketee and Walsh, 2005) . In addition to sensitization, studies have shown that intramPFC self-administration of cocaine can be blocked by co-administration of sulpiride (Goeders and Smith, 1983) . Taken together, these data suggest that sensitization and drug-seeking results, at least in part, from a reduction in D 2 -mediated inhibition of excitatory output neurons that innervate the NAc and VTA.
Adaptations in D 2 R signaling in mPFC layer 5/6 interneurons
In addition to regulating layer 5/6 pyramidal cell activity, DA can regulate mPFC glutamatergic output indirectly by acting at D 2 R found on local inhibitory interneurons and modulating the excitability of GABA-containing neurons and subsequent GABA release within the mPFC (Sesack et al., 1995; Grobin and Deutch, 1998; Seamans and Yang, 2004; Nogueira et al., 2006) . Recently, it was demonstrated in acutely-isolated PFC slices that repeated cocaine and prolonged withdrawal reduced D 2 R-dependent inhibition of evoked and spontaneous inhibitory postsynaptic currents (IPSCs) in cortical interneurons (Kroener and Lavin, 2010) . This reduction in D 2 R-modulation correlated with an increase in action potential-independent (spontaneous) GABA release within the mPFC. (Kroener and Lavin, 2010) . This loss of D 2 R-dependent signaling resulted in a shift towards D 1 R-dependent signaling that augmented the excitability of layer 5/6 GABA-containing neurons in the mPFC (Kroener and Lavin, 2010) . These findings are consistent with previous reports of increased extracellular GABA within the mPFC of cocaine sensitized rats and suggest that repeated cocaine significantly reduces the function of D 2 R in both excitatory and inhibitory neurons within the mPFC (Jayaram and Steketee, 2005; Nogueira et al., 2006; Kroener and Lavin, 2010) .
D 2 R adaptations in mPFC layer 5/6 interneurons and addiction-related behavior
Cortical interneurons are well positioned to gate inputs and shape the output of layer 5/6 pyramidal neurons (Compte et al., 2000; McBain and Fisahn, 2001; Lapish et al., 2007) . This gating is important for cognitive function, and is thought to be optimized through DAdependent modulation of interneuron firing in the mPFC (Tierney et al., 2008) . Therefore, cocaine-induced changes in this modulation may disrupt signal processing within the mPFC that is important to cognition and goal-directed behavior (Kroener et al., 2009) .
DA release in the mPFC can decrease overall cortical activity while still increasing evoked firing of pyramidal neurons (Kroener et al., 2009 ). Repeated cocaine exposure may reduce D 2 R-function in mPFC GABAergic interneurons, leaving an unopposed D 1 R-mediated enhancement of GABA release in the cortex. Increased GABA release would in turn reduce basal glutamate release to subcortical targets and disrupt processing of motivating stimuli that drive behavior (Franklin and Druhan, 2000; Durstewitz and Seamans, 2008) . This idea is consistent with previous reports of reduced basal extracellular glutamate levels in the NAc following repeated cocaine exposure . Furthermore, this type of disruption is akin to the drug-induced hypofrontality observed in humans that is believed to bring about a reduction in inhibitory control over maladaptive behavior and the emergence of compulsive drug-seeking in addicts Goldstein and Volkow, 2002; Feil et al., 2010; Koob and Volkow, 2010) . Additionally, alterations in cognitive function are thought to underlie decreased motivation to respond to non-drugrelated stimuli seen in drug-dependent individuals, leaving only strong motivational stimuli such as drug-associated cues to ably activate mPFC networks and initiate behavior Maas et al., 1998; Childress et al., 1999; London et al., 2000; Volkow and Fowler, 2000; Franklin et al., 2002; Matochik et al., 2003; .
GABA B R adaptations in mPFC layer 5/6 pyramidal neurons and addiction-related behavior
Alterations in GABAergic signaling in the mPFC plays an important role in modulating drug-related behavior following repeated cocaine treatment. For example, ventral but not dorsal mPFC infusions of a GABAergic agonist cocktail (muscimol and baclofen) decreased cue-induced cocaine seeking following prolonged withdrawal, while antagonists (bicuculline and saclofen) dramatically increased extinction responding following 1 day of withdrawal (Koya et al., 2009) . Of specific relevance to GABA B R-dependent signaling, infusion of baclofen into the ventral portion of the mPFC blocked acute cocaine-induced motor activity and the development of behavioral sensitization when administered prior to each cocaine injection (Jayaram and Steketee, 2004; . However, the ability of baclofen to decrease cocaine-induced activity was lost in previouslysensitized rats, providing indirect evidence that repeated cocaine reduces the functional capability of GABA B R signaling in the mPFC Steketee, 2004, 2005) . Consistent with this, recent findings from our lab indicate that repeated but not acute cocaine suppresses GABA B RGirk signaling in the mouse mPFC (Hearing et al., unpublished data) .
In addition to regulating behavioral components of addiction, alterations in GABA signaling in the mPFC following cocaine exposure modify DA and glutamatergic neurotransmission in the mesocorticolimbic system. For instance, following baclofen infusion into the ventral mPFC, drug-na ï ve animals show less glutamate release in the VTA and NAc, while cocaine-treated animals exhibit elevated glutamate in these brain regions (Jayaram and Stekettee, 2004) . Similar results were observed following dorsal PFC infusions of baclofen, which decreased extracellular DA in drug na ï ve animals, while an antagonist (phaclofen) increased DA levels (Santiago et al., 1993) . Such data support the conclusion that psychostimulants impair the ability of GABA B R-dependent signaling to regulate neurotransmission within the mPFC, as well as glutamate output from the mPFC, which is critical for the expression of addiction-related behavior.
Mechanisms underlying adaptations in mPFC D 2 R and GABA B R signaling Receptor expression and G proteins
Evidence suggests that cocaine-induced reductions in D 2 R function in the mPFC likely reflects, in part, a decrease in receptor expression and/or stability. Indeed, reduced D 2 R binding has been observed in multiple regions of the frontal cortex of cocaine-dependent individuals, while rats exhibited decreased quinpirole-mediated GTP γ S binding in the mPFC following repeated cocaine exposure (Volkow and Fowler, 2000; Bowers et al., 2004) . Furthermore, rats with either a history of non-contingent cocaine exposure or cocaine self-administration displayed reduced D 2 R protein expression, the latter of which correlated with persistent deficits in cognitive tasks that require an intact mPFC (Kleven et al., 1990; Briand et al., 2008) . While many studies have reported reduced function of mPFC GABA B R-dependent signaling following psychostimulant exposure, no changes in total receptor or G i/o protein levels have been reported (Striplin and Kalivas, 1992; Li et al., 2002; Jayaram and Stekettee, 2004) . Moreover, there does not appear to be a functional change in GABA B R coupling to G i/o proteins, as measured by baclofen-induced GTP γ S binding in the PFC following repeated cocaine exposure (Kushner and Unterwald, 2001 ).
Effectors
Cocaine-induced weakening of GABA B R and D 2 R-dependent pathways that normally regulate mPFC Layer 5/6 pyramidal neurons _ENREF_56 offers a potential explanation for the enhanced mPFC glutamatergic output associated with behavioral sensitization (Jayaram and Steketee, 2004; Noguiera et al., 2006; Liu and Steketee, 2011) . At present, however, little is known regarding the effectors that mediate the inhibitory influence of GABA B R and D 2 R in neurons that project to the VTA and NAc. In vitro and in vivo electrophysiological studies from adolescent and adult rats show that repeated cocaine increased burst firing of layer 5/6 pyramidal neurons of the mPFC in response to cocaine-associated information, and enhanced membrane excitability by suppressing voltage-gated and inwardlyrectifying K + currents and enhancing voltage-gated L-type Ca 2+ currents (Dong et al., 2005; Nasif et al., 2005; Sun and Rebec, 2006) . Consistent with this, unpublished findings from our laboratory indicate that Girk channels mediate most of the GABA B R-dependent postsynaptic inhibitory effects in layer 5/6 pyramidal neurons of the mouse mPFC, and that repeated cocaine suppresses GABA B R-Girk signaling in these cells (Hearing et al., unpublished) . Thus, repeated drug exposure may temper GABA B R and/or D 2 Rdependent signaling in layer 5/6 pyramidal neurons of the mPFC by altering the levels of Girk channels or other downstream effectors, as was shown in VTA DA neurons (Kushner and Unterwald, 2001; Arora et al., 2011 ).
An additional mechanism by which cocaine may alter mPFC pyramidal cell excitability is through modulation of the cAMP/PKA signaling pathway. PKA can phosphorylate K + channels and consequently decrease K + currents, and repeated exposure to cocaine has been shown to up-regulate the cAMP/PKA pathway in mPFC Layer 5/6 pyramidal neurons neurons (Dong and White, 2003; Dong et al., 2005) . Given that G i/o -dependent signaling negatively-regulates AC activity, increased cAMP/PKA signaling in the mPFC may be due in part to reduced inhibitory modulation via GPCRs such as D 2 R or GABA B R.
Regulatory proteins
Changes in the level or function of RGS and AGS proteins could also underlie cocaine-induced alterations in G protein-dependent signaling. For example, Rgs4 is a forebrain-enriched RGS isoform, expression of which has shown to be dynamically-regulated by activation of DA receptors in response to acute psychostimulant administration (Taymans et al., 2003; Schwendt et al., 2006; Schwendt and McGinty, 2007; Schwendt and McGinty, 2010) . Although Rgs4 expression is regulated by D 1 R and D 2 R, Rgs4 does not appear to exercise direct effects on D 2 R signaling (Taymans et al., 2003; Ding et al., 2006; Schwendt et al., 2006) . Changes in Rgs4 expression, however, do appear to alter signaling via other GPCRs, including GABA B R (Abramow-Newerly et al., 2006). Thus, cocaine-induced adaptations in DA signaling may indirectly alter GABA B R-dependent signaling in an Rgs4-dependent manner.
Following prolonged withdrawal from chronic binge-cocaine exposure or cocaine self-administration, Rgs4 mRNA is significantly decreased in the rat mPFC (Schwendt and McGinty, 2007) . Furthermore, re-exposure to a cocaine-associated context following abstinence from self-administration restored levels of Rgs4 mRNA to that of control rats (Schwendt and McGinty, 2007) . As Rgs4 is a negative regulator of several G i/o -coupled receptors, a reduction in Rgs4 expression would be expected to disinhibit (enhance) inhibitory signaling. However, repeated cocaine appears to reduce GABA B R function (Jayaram and Steketee, 2004) . In addition to regulating G i -signaling, Rgs4 plays a significant role in modulating the G q class of G proteins (Schwendt and McGinty, 2007; Schwendt et al., 2011) , thus it is possible that cocaine-induced reductions in mPFC Rgs4 levels alters G q -but not G i/o -dependent sig naling. Regardless, cocaine-induced changes in the expression and/or function of Rgs4 in the mPFC may translate into widespread modifications in a number of G protein-dependent signaling pathways.
Cocaine-induced suppression of D 2 R and GABA B Rdependent signaling in the mPFC of animals treated repeatedly with psychostimulants may also result from elevated levels of AGS proteins. Indeed, Ags3 mRNA and protein are significantly elevated in the rodent mPFC following repeated cocaine exposure (Bowers et al., 2004) . These alterations have been shown to persist for up to 8 weeks of withdrawal (Bowers et al., 2004; Frankowska et al., 2008) , thus representing an enduring molecular adaptation that may in part promote the persistence of addicted behavior. Indeed, up-regulation of Ags3 expression in the mPFC produced a heightened motor-stimulatory response to a single cocaine injection normally observed followed repeated cocaine exposure (Bowers et al., 2004) . Increased Ags3 expression also elevated levels of extracellular glutamate in the NAc and enhanced drug-seeking behavior in self-administering rats when primed with a single cocaine injection (Bowers et al., 2004) . Moreover, reduced Ags3 expression in the mPFC restored chronic cocaine-induced reductions in D 2 R-mediated signaling in the mPFC and blocked behavioral sensitization and reinstatement of drug-seeking behavior (Bowers et al., 2004) . It is possible that up-regulation of Ags3 in the mPFC and subsequent decreases in G i/o -dependent metabotropic signaling via D 2 Rs may result in a shift towards G s -dependent signaling. This would be predicted to enhance cAMPdependent signaling, as well as downstream transcription factors that may in turn promote increased excitability of cortical neurons projecting to the NAc and VTA. Regardless of the exact mechanisms, these findings exemplify the importance of mPFC G i/o -dependent signaling in the development and persistence of addicted behavior.
Conclusion
Repeated cocaine exposure reduces basal activity and glutamate release from the mPFC to subcortical regions important for the expression of addicted behavior (Childress et al., 1999; Baker et al., 2003; Steketee and Kalivas, 2011) . In contrast, the mPFC, including the layer 5/6 pyramidal neurons, is more responsive when exposed to drug-associated cues, promoting enhanced glutamate release within the NAc (Childress et al., 1999; Baker et al., 2003; Sun and Rebec, 2006) . This dichotomy of effects may be explained in part, by a reduction in metabotropic inhibitory signaling within both excitatory and inhibitory neurons of the mPFC. Reduced D 2 R or GABA B R-dependent inhibitory signaling in GABA interneurons likely promotes increased GABA release within the mPFC that may contribute to reductions in overall basal activity (hypofrontality). Hypofrontality may in turn reduce the motivation to respond to non-drug-related stimuli, leaving only strong motivational stimuli, such as drug-associated cues, to ably activate PFC networks and initiate behavior Kroener and Lavin, 2010) . Alternatively, increased responsiveness to drug-associated cues may reflect reductions in D 2 R or GABA B R-dependent inhibitory signaling in layer 5/6 pyramidal neurons that increases glutamate release necessary for driving addicted behavior.
Although there have been important advances in our understanding of the neural adaptations underlying the development of addiction and the persistent vulnerability to relapse, a better understanding of signaling pathways, inhibitory and excitatory, that mediate the cellular and behavioral effects of drugs of abuse, will ultimately improve the way in which we understand and address addiction as a progressive disease.
While a wealth of evidence highlights the importance of cocaine-induced adaptations in excitatory neurotransmission in the development and expression of addicted behavior, the material covered in this review collectively indicates that cocaine-induced neuroadaptations in metabotropic inhibitory signaling mediated by two prominent G protein-coupled receptors -the GABAB and D12 dopamine receptors -in the VTA and mPFC likely constitute an 'addiction barrier' that is overcome by exposure to cocaine and perhaps other drugs of abuse. Such drug-evoked synaptic plasticity may constitute an early cellular mechanism, eventually causing compulsive drug-seeking behavior in some drug users. While vulnerability to relapse affords an opportunity for pharmacotherapeutic intervention, our limited understanding of the neurochemical, molecular, and cellular mechanisms that lead to the persistent expression of drug-related behavior has impeded us in this regard. Thus it is important to elucidate the induction criteria for addiction. One way to achieve this is by gaining a better understanding the molecular and cellular mechanisms responsible for drug-induced changes in inhibitory signaling, and how these changes reorganize and functionally alter neuronal circuits that eventually lead to behaviors that define addiction. His pre-doctoral research focused on mapping the selective regional patterns and identifying the function of activity-regulated genes in a variety of brain areas, including the prefrontal cortex, striatum, hippocampus and amygdala, in context-dependent relapse and extinction of drug-seeking in rats. Currently, he is a postdoctoral fellow at the University of Minnesota in the Department of Pharmacology, where he is exploring the role of inhibitory metabotropic signaling within the mesocorticolimbic system in associative learning, mood disorders, and reward-related behavior. His research utilizes a number of neurobehavioral animal models in conjunction with slice electrophysiology and pharmacological manipulation of receptor signaling and gene expression.
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